In October 2025, Tengyi Boshi officially obtained the WHO GDP certification issued by the World Health Organization, marking that the company's drug warehousing, distribution, and cross-border temperature control operation system fully meets the highest regulatory standards for drug circulation in the European Union. It has become one of the few professional pharmaceutical cold chain service providers in China that holds both domestic GSP and EU GDP qualifications, laying a solid international regulatory foundation for the import and export distribution of domestic and foreign pharmaceutical companies.
The WHO GDP is the authoritative access standard for global pharmaceutical circulation issued by the World Health Organization. It sets strict audit thresholds for warehouse management, temperature control monitoring, batch traceability, personnel control, emergency response, and other special drugs such as vaccines, biologics, innovative drugs, and clinical reagents. It is a mandatory prerequisite for local distribution and transit of drugs entering the EU market. This certification audit covers six core modules, including the division of all temperature distribution areas, 24-hour uninterrupted temperature and humidity traceability, data tamper proof retention, full process risk control, and professional compliance team system, fully verifying the standardization, normalization, and internationalization capabilities of Tengyi Boshi's pharmaceutical distribution business.
Having been deeply involved in cross-border life science cold chain for many years, Tengyi Boshi has established a full temperature storage and distribution system covering liquid nitrogen ultra-low temperature to room temperature. We have independently developed long-term passive aviation refrigerated containers and laid out a pharmaceutical cold chain transportation network that connects China and Europe and radiates globally. With multiple authoritative endorsements such as AEO advanced customs certification, IATA aviation pharmaceutical qualification, ISO quality management system, etc., we have formed a complete pharmaceutical logistics qualification matrix. Relying on mature hardware and digital control systems, the company's distribution operations can achieve full traceability of each batch of drug circulation information, with temperature control data retained for one year after the expiration date of the drug. The supporting mechanisms such as abnormal temperature zone warning and emergency cooling plan fully match EU regulatory requirements, meeting the high standard distribution needs of high-value biopharmaceuticals and clinical trial samples.
The landing of the GDP certificate this time complements Tengyi Boshi's key capabilities in global compliance allocation. For domestic innovative pharmaceutical companies, there is no need to connect with overseas third-party warehousing service providers, and they can rely on Tengyi Boshi to complete the entire process of global drug transit, distribution, and storage, greatly simplifying the outbound process and reducing cross-border compliance costs; At the same time, it can also undertake outsourcing and distribution business for multinational pharmaceutical companies, expanding the track of high value-added pharmaceutical cold chain services.
As a participating drafting unit in the domestic pharmaceutical cold chain industry standards, Tengyi Boshi takes the WHO GDP certification as a new starting point and continues to promote the alignment of domestic pharmaceutical circulation norms with international advanced standards. In the future, enterprises will continue to improve the global pharmaceutical distribution compliance system, upgrade the digital temperature control traceability platform, rely on the advantages of dual standard compliance, and provide safer, more efficient, and compliant global cold chain distribution solutions for domestic and foreign pharmaceutical enterprises, safeguarding the high-quality development of the global pharmaceutical circulation industry with professional logistics strength.
